Formation of a Precision Oncology Registry
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 入组人数
- 2,885
- 试验地点
- 1
- 主要终点
- Populations Requiring Financial Assistance
研究概览
简要总结
In efforts to develop an aggregation point for patient clinical data and data related to DNA sequencing in the Comprehensive Cancer Center, this registry will be developed to provide a comprehensive data store. The goal of the registry will be to collect information on the Cancer Center population undergoing next generation DNA sequencing (NGS) on their tumors or liquid biopsies.
详细描述
PRIMARY OBJECTIVES:
I. To capture characteristics of the patient population undergoing next generation deoxyribonucleic acid (DNA) sequencing of their tumor or liquid biopsy for more efficient clinical operations by collecting data on demographics, disease, and previous treatment.
II. To gather information on the number and type of patients that receive off label, standard, timeline or other experimental treatments based on the next generation sequencing (NGS) data.
III. To gather data regarding the patient population that may require financial assistance.
IV. To describe the patient population, in terms of demographic and clinical characteristics, who have consented to have their next generation sequencing data to be linked to their clinical records and used for future research.
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •All cancer patients at Wake Forest Baptist Comprehensive Cancer Center and its satellites who are having next generation DNA sequencing ordered/performed on their tumor biopsy or surgically resected tissue and/or blood samples.
排除标准
- •Not applicable
结局指标
主要结局
Populations Requiring Financial Assistance
时间窗: Approximately 2 years
To gather data regarding the patient population that may require financial assistance
Modes of Treatment for Patients
时间窗: Approximately 2 years
To gather information on the number and type of patients that receive off label, standard, timeline or other experimental treatments based on the NGS data.
Overall Survival
时间窗: Approximately 2 years
To collect overall survival for those patients with NGS data
Outcome and Response to Different Forms of Treatment
时间窗: Approximately 2 years
To collect outcomes and response to the standard, experimental and/or off label treatment
Data Collection of Demographics, Disease and Previous Treatment
时间窗: Approximately 2 years
To capture characteristics of the patient population undergoing next generation DNA sequencing of their tumor or liquid biopsy for more efficient clinical operations by collecting data on demographics, disease, and previous treatment.
Demographics Collection to Assess Patient Population
时间窗: Approximately 2 years
To describe the patient population, in terms of demographic, who have consented to have their NGS data to be linked to their clinical records and used for future research
Clinical Characteristics of Disease
时间窗: Approximately 2 years
To describe the patient population, in terms clinical characteristics, who have consented to have their NGS data to be linked to their clinical records and used for future research
次要结局
未报告次要终点